+ ethambutol tablet, 100 mg-400 mg (hydrochloride)

+ isoniazid tablet, 100-300 mg

+ isoniazid + ethambutol tablet, 150 mg + 400 mg

+ pyrazinamide tablet, 400 mg

+ rifampicin capsule or tablet, 150 mg, 300 mg

+ rifampicin + isoniazid "tablet, 60 mg + 30 mg

+ rifampicin + isoniazid + pyrazinamide "tablet, 60 mg + 30 mg + 150 mg

+  "tablet, 60 mg + 30 mg + 150 mg

+ rifampicin + isoniazid + pyrazinamide + ethambutol tablet, 150 mg + 75 mg + 400 mg + 275 mg

+ streptomycin powder for injection, 1 g (as sulfate) in vial

+ Complementary List 

+ Reserve second-line drugs for the treatment of multidrug-resistant tuberculosis (MDR-TB) should be used in specialized centres adhering to WHO standards for TB control. These medicines will be reviewed at the next meeting of the Expert Committee. 

+ amikacin powder for injection, 1000 mg in vial

+ p-aminosalicylic acid "tablet, 500 mg

+ capreomycin powder for injection, 1000 mg in vial

+ ciprofloxacin tablet, 250 mg, 500 mg

+ cycloserine capsule or tablet, 250 mg

+ ethionamide tablet, 125 mg, 250 mg

+ kanamycin powder for injection, 1000 mg in vial

+ levofloxacin tablet, 250 mg, 500 mg

+ ofloxacin tablet, 200 mg, 400 mg